Cerebrovascular "Moyamoya" Disease

1969/03/01 by Jiro Suzuki, Jirô Suzuki · 27 citations
Medicine · #Moyamoya disease diagnosis and treatment #Neurological Complications and Syndromes #Intracranial Aneurysms: Treatment and Complications

paper · doi:10.1001/archneur.1969.00480090076012

Cited by

• Cerebral Hemorrhage: Pathophysiology, Treatment, and Future Directions
• Clinical features and long-term outcomes of moyamoya disease: a single-center experience with 528 cases in China
• The relationship between cerebral infarction and angiographic characteristics in childhood moyamoya disease. [europepmc]
• "Ivy sign" on fluid-attenuated inversion-recovery images in childhood moyamoya disease. [europepmc]
• Cerebral hemodynamics in Moyamoya disease: correlation between perfusion-weighted MR imaging and cerebral angiography. [europepmc]
• The acetazolamide challenge: techniques and applications in the evaluation of chronic cerebral ischemia. [europepmc]
• The leptomeningeal "ivy sign" on fluid-attenuated inversion recovery MR imaging in Moyamoya disease: a sign of decreased cerebral vascular reserve? [europepmc]
• Quantitative hemodynamic studies in moyamoya disease: a review. [europepmc]
• Clinical features, surgical treatment, and long-term outcome in adult patients with moyamoya disease. Clinical article. [europepmc]
• Diverse roles of the vasculature within the neural stem cell niche. [europepmc]
• "Brush Sign" on susceptibility-weighted MR imaging indicates the severity of moyamoya disease. [europepmc]
• Arterial spin-labeling MRI can identify the presence and intensity of collateral perfusion in patients with moyamoya disease. [europepmc]
• CBF measurements using multidelay pseudocontinuous and velocity-selective arterial spin labeling in patients with long arterial transit delays: comparison with xenon CT CBF. [europepmc]
• Relationships between hypercarbic reactivity, cerebral blood flow, and arterial circulation times in patients with moyamoya disease. [europepmc]
• Vascular remodeling after ischemic stroke: mechanisms and therapeutic potentials. [europepmc]
• Collaterals: Implications in cerebral ischemic diseases and therapeutic interventions. [europepmc]
• Added Value of Vessel Wall Magnetic Resonance Imaging in the Differentiation of Moyamoya Vasculopathies in a Non-Asian Cohort. [europepmc]
• Multiparametric estimation of brain hemodynamics with MR fingerprinting ASL. [europepmc]
• Long-Delay Arterial Spin Labeling Provides More Accurate Cerebral Blood Flow Measurements in Moyamoya Patients: A Simultaneous Positron Emission Tomography/MRI Study. [europepmc]
• Imaging of Moyamoya Disease and Moyamoya Syndrome: Current Status. [europepmc]
• Epidemiology, diagnosis and treatment of moyamoya disease. [europepmc]
• Influence of Inflammatory Disease on the Pathophysiology of Moyamoya Disease and Quasi-moyamoya Disease. [europepmc]
• Predictive role of heterozygous p.R4810K of RNF213 in the phenotype of Chinese moyamoya disease. [europepmc]
• Progression in Moyamoya Disease: Clinical Features, Neuroimaging Evaluation, and Treatment. [europepmc]
• The Genetic Basis of Moyamoya Disease. [europepmc]
• Ring finger protein 213 assembles into a sensor for ISGylated proteins with antimicrobial activity. [europepmc]
• Cerebral Hemorrhage: Pathophysiology, Treatment, and Future Directions. [europepmc]